Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 241

1.

Noncoding RNAs in Depression.

Lin R, Turecki G.

Adv Exp Med Biol. 2017;978:197-210. doi: 10.1007/978-3-319-53889-1_11. Review.

PMID:
28523548
2.

Histone Modifications in Major Depressive Disorder and Related Rodent Models.

Deussing JM, Jakovcevski M.

Adv Exp Med Biol. 2017;978:169-183. doi: 10.1007/978-3-319-53889-1_9. Review.

PMID:
28523546
3.

The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies.

Amare AT, Schubert KO, Klingler-Hoffmann M, Cohen-Woods S, Baune BT.

Transl Psychiatry. 2017 Jan 24;7(1):e1007. doi: 10.1038/tp.2016.261. Review.

4.

Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.

Marshe VS, Maciukiewicz M, Rej S, Tiwari AK, Sibille E, Blumberger DM, Karp JF, Lenze EJ, Reynolds CF 3rd, Kennedy JL, Mulsant BH, Müller DJ.

Am J Psychiatry. 2017 May 1;174(5):468-475. doi: 10.1176/appi.ajp.2016.16050617. Epub 2017 Jan 10.

PMID:
28068779
5.

Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression.

Rhein C, Reichel M, Kramer M, Rotter A, Lenz B, Mühle C, Gulbins E, Kornhuber J.

J Affect Disord. 2017 Feb;209:10-15. doi: 10.1016/j.jad.2016.09.019. Epub 2016 Sep 28.

PMID:
27866044
6.

Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.

Li QS, Tian C, Seabrook GR, Drevets WC, Narayan VA.

Transl Psychiatry. 2016 Sep 13;6(9):e889. doi: 10.1038/tp.2016.171.

7.

Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory.

Zoicas I, Reichel M, Gulbins E, Kornhuber J.

PLoS One. 2016 Sep 6;11(9):e0162498. doi: 10.1371/journal.pone.0162498. eCollection 2016.

8.

Progress and prospects in pharmacogenetics of antidepressant drugs.

Fabbri C, Crisafulli C, Calabrò M, Spina E, Serretti A.

Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1157-68. doi: 10.1080/17425255.2016.1202237. Epub 2016 Jun 27. Review.

PMID:
27310483
9.

Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial.

Bahramali E, Firouzabadi N, Yavarian I, Shayesteh MR, Erfani N, Shoushtari AA, Asadpour R.

Eur J Clin Pharmacol. 2016 Sep;72(9):1059-64. doi: 10.1007/s00228-016-2079-0. Epub 2016 Jun 5.

PMID:
27262302
10.

Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.

Noordam R, Avery CL, Visser LE, Stricker BH.

Pharmacogenomics. 2016 Jun;17(9):1029-40. doi: 10.2217/pgs-2016-0024. Epub 2016 Jun 1. Review.

11.

Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.

Mellon SH, Wolkowitz OM, Schonemann MD, Epel ES, Rosser R, Burke HB, Mahan L, Reus VI, Stamatiou D, Liew CC, Cole SW.

Transl Psychiatry. 2016 May 24;6:e821. doi: 10.1038/tp.2016.79.

12.

The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.

Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR.

BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x.

13.

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway.

Cocchi E, Fabbri C, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU, Serretti A.

BMC Psychiatry. 2016 Apr 18;16:106. doi: 10.1186/s12888-016-0813-x.

14.

Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder.

Iga J, Watanabe SY, Numata S, Umehara H, Nishi A, Kinoshita M, Inoshita M, Shimodera S, Fujita H, Ohmori T.

Hum Psychopharmacol. 2016 May;31(3):193-9. doi: 10.1002/hup.2527. Epub 2016 Mar 23.

PMID:
27005686
15.

Epigenetic regulation of BDNF in the learned helplessness-induced animal model of depression.

Su CL, Su CW, Hsiao YH, Gean PW.

J Psychiatr Res. 2016 May;76:101-10. doi: 10.1016/j.jpsychires.2016.02.008. Epub 2016 Feb 13.

PMID:
26921875
16.

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.

Gupta M, Neavin D, Liu D, Biernacka J, Hall-Flavin D, Bobo WV, Frye MA, Skime M, Jenkins GD, Batzler A, Kalari K, Matson W, Bhasin SS, Zhu H, Mushiroda T, Nakamura Y, Kubo M, Wang L, Kaddurah-Daouk R, Weinshilboum RM.

Mol Psychiatry. 2016 Dec;21(12):1717-1725. doi: 10.1038/mp.2016.6. Epub 2016 Feb 23.

17.

Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.

Su YA, Li JT, Dai WJ, Liao XM, Dong LC, Lu TL, Bousman C, Si TM.

Int Clin Psychopharmacol. 2016 May;31(3):127-33. doi: 10.1097/YIC.0000000000000115.

PMID:
26745768
18.

Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.

Breitenstein B, Scheuer S, Brückl TM, Meyer J, Ising M, Uhr M, Holsboer F.

J Psychiatr Res. 2016 Feb;73:86-95. doi: 10.1016/j.jpsychires.2015.11.010. Epub 2015 Nov 24.

PMID:
26704739
19.

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.

Stamm TJ, Rampp C, Wiethoff K, Stingl J, Mössner R, O Malley G, Ricken R, Seemüller F, Keck M, Fisher R, Gaebel W, Maier W, Möller HJ, Bauer M, Adli M.

J Psychopharmacol. 2016 Jan;30(1):40-7. doi: 10.1177/0269881115620459. Epub 2015 Dec 8.

PMID:
26645208
20.

Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.

Eyre HA, Eskin A, Nelson SF, St Cyr NM, Siddarth P, Baune BT, Lavretsky H.

Int J Geriatr Psychiatry. 2016 May;31(5):510-7. doi: 10.1002/gps.4356. Epub 2015 Oct 15.

Supplemental Content

Loading ...
Support Center